Study to evaluate the ability of a novel software program to diagnose and track the progression of Alzheimer's disease using MEG/EEG

The purpose of this study is to examine the ability of a specialized computer program to diagnose and track disease progression in individuals with mild-to-moderate Alzheimer's disease (AD). The program analyzes data collected by means of magnetoencephalography (MEG) and electroencephalography (EEG).  MEG and EEG are non-invasive imaging techniques that allow researchers to measure the magnetic fields and electrical activity produced by the brain.

The study, which is being conducted by the Rush Alzheimer's Disease Center, is sponsored and funded by Orasi Medical, Inc. We expect to recruit approximately 60 individuals to participate.

Duration of the study is approximately 1 month and will require 3 study visits. The first visit will determine your eligibility to participate. The second and third visits will include testing of your memory and MEG/EEG scans.

There will be no cost to people who join the study. All study visits will be covered by the research study.

You may be eligible to participate in this study if you:

• Have a diagnosis of mild to moderate Alzheimer's disease [a Mini-Mental State Examination (MMSE) Score ≥ 16], or be in good general health with no memory problems [MMSE  ≥ 26]
• Are 50-90 years of age
• Do not smoke
• Speak English

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.